Approval · Notice of Compliance 6631 · 2005
RABAVERT: Notice of Compliance 6631
Issued April 29, 2005
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 6631
- Date
- April 29, 2005
- Company
- Chiron Behring Gmbh & Co Kg
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Active immunizing agent
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| RABAVERT | 02267667 | Marketed |
Medicinal ingredients
- RABIES VACCINE (PURIFIED CHICK EMBRYO CELL CULTURE) 2.5 UNIT per DOSE